Abstract
The original article [1] contained an error in co-author, Lars Bertram’s affiliation which has since been corrected.
| Original language | English |
|---|---|
| Article number | 37 |
| Pages (from-to) | 1-2 |
| Number of pages | 2 |
| Journal | Molecular Neurodegeneration |
| Volume | 17 |
| Early online date | 13 May 2022 |
| DOIs | |
| Publication status | Published - 2022 |
Bibliographical note
Correction to: Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease (Molecular Neurodegeneration, (2022), 17, 1, (27), DOI 10.1186/s13024-022-00521-3).Publisher Copyright:
© 2022, The Author(s).
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 16 Peace, Justice and Strong Institutions
Fingerprint
Dive into the research topics of 'Correction: Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease'. Together they form a unique fingerprint.Research output
- 4 Citations
- 1 Article
-
Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer's disease
ADNI, 2022, In: Molecular Neurodegeneration. 17, p. 1-16 16 p., 27.Research output: Contribution to Journal › Article › Academic › peer-review
Open Access
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver